Brown, Lisle/Cummings’s Oracle ORCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$654K Buy
4,464
+117
+3% +$21.2K 0.15% 138
2026
Q1
$639K Sell
4,347
-18
-0.4% -$2.93K 0.16% 125
2025
Q4
$851K Buy
4,365
+1,650
+61% +$393K 0.21% 110
2025
Q3
$764K Hold
2,715
0.2% 113
2025
Q2
$594K Hold
2,715
0.16% 131
2025
Q1
$380K Buy
2,715
+55
+2% +$8.95K 0.11% 171
2024
Q4
$443K Buy
2,660
+250
+10% +$44.4K 0.13% 153
2024
Q3
$411K Hold
2,410
0.12% 153
2024
Q2
$340K Buy
2,410
+375
+18% +$46.6K 0.11% 163
2024
Q1
$256K Hold
2,035
0.09% 179
2023
Q4
$215K Buy
2,035
+235
+13% +$25.6K 0.08% 189
2023
Q3
$191K Hold
1,800
0.09% 187
2023
Q2
$214K Sell
1,800
-250
-12% -$25.8K 0.1% 170
2023
Q1
$190K Hold
2,050
0.1% 171
2022
Q4
$168K Hold
2,050
0.09% 170
2022
Q3
$125K Hold
2,050
0.07% 191
2022
Q2
$143K Sell
2,050
-380
-16% -$27.8K 0.08% 186
2022
Q1
$201K Hold
2,430
0.1% 165
2021
Q4
$212K Buy
+2,430
New +$228K 0.11% 160

Other funds holding ORCL

Brown, Lisle/Cummings's ORCL Position: Q2 2026 in Review

Brown, Lisle/Cummings increased its Oracle (ORCL) stake by 2.7% in Q2 2026, buying an estimated $21.2K and bringing the position to 4,464 shares worth $654K. The position accounts for 0.15% of the portfolio, ranked #138.

Brown, Lisle/Cummings first reported a position in ORCL in Q4 2021 and has held it in 19 quarters since. The position peaked at $851K in Q4 2025. 3,519 funds tracked by Wall St. Rank hold ORCL as of Q2 2026.

  • Brown, Lisle/Cummings held 4,464 shares of Oracle worth $654K as of Q2 2026.
  • Brown, Lisle/Cummings bought 117 Oracle shares in Q2 2026, an estimated $21.2K.
  • Oracle made up 0.15% of Brown, Lisle/Cummings's portfolio in Q2 2026, its #138 holding.
  • Brown, Lisle/Cummings first reported a position in Oracle in Q4 2021 and has held it in 19 quarters since.
  • Brown, Lisle/Cummings's Oracle position peaked at $851K in Q4 2025.
  • 3,519 funds tracked by Wall St. Rank held Oracle as of Q2 2026.

Based on Brown, Lisle/Cummings's 13F filing for Q2 2026, filed 2 Sep 2026.